125 related articles for article (PubMed ID: 29277666)
1. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
[TBL] [Abstract][Full Text] [Related]
2. Two tandem repeats of mHSP70
Xu M; Zhang Y; Dong W; Jiang L; Zhang J; Yu P; Xie S; Zhou L
Life Sci; 2018 May; 201():102-110. PubMed ID: 29572180
[TBL] [Abstract][Full Text] [Related]
3. Low-dose docetaxel enhances the anti-tumour efficacy of a human umbilical vein endothelial cell vaccine.
Zhou L; Lu M; Zhong W; Yang J; Yin Y; Li M; Li D; Zhang S; Xu M
Eur J Pharm Sci; 2020 Jan; 142():105163. PubMed ID: 31756447
[TBL] [Abstract][Full Text] [Related]
4. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
[TBL] [Abstract][Full Text] [Related]
5. [Study on the specific immunity of dendritic cell vaccine loading human umbilical vein endothelial cell antigen against U14 cervical cancer].
Zhao J; Zhai JM; Lu J; Yang HY; Huang YT; Li S; Dong ZM; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):196-200. PubMed ID: 19257979
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.
Xu M; Zhou L; Zhang P; Lu Y; Ge C; Yao W; Xing Y; Xiao W; Dong Y; Wu J; Cao R; Li T
Tumour Biol; 2013 Oct; 34(5):3173-82. PubMed ID: 23771850
[TBL] [Abstract][Full Text] [Related]
7. Fusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.
Mu X; Fang C; Zhou J; Xi Y; Zhang L; Wei Y; Yi T; Wu Y; Zhao X
J Cancer Res Clin Oncol; 2016 Jan; 142(1):111-23. PubMed ID: 26139353
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
9. Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.
Li J; Xing Y; Zhou Z; Yao W; Cao R; Li T; Xu M; Wu J
Tumour Biol; 2016 Nov; 37(11):15097-15105. PubMed ID: 27662838
[TBL] [Abstract][Full Text] [Related]
10. Combination of Human Umbilical Vein Endothelial Cell Vaccine and Docetaxel Generates Synergistic Anti-Breast Cancer Effects.
Lu M; Yao Q; Liu H; Zhong W; Gao J; Si C; Zhou L; Zhang S; Xu M
Cancer Biother Radiopharm; 2019 Sep; 34(7):464-471. PubMed ID: 31009240
[No Abstract] [Full Text] [Related]
11. Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model.
Liu H; Zhao J; Yang Y; Jin G; Zhang X; Wang D; Xie C; Liu K; Chen X; Li X; Tian F; Dong Z; Lu J
Oncol Rep; 2018 Nov; 40(5):3006-3014. PubMed ID: 30132560
[TBL] [Abstract][Full Text] [Related]
12.
Si C; Xu M; Lu M; Yu Y; Yang M; Yan M; Zhou L; Yang X
Oncol Lett; 2017 Dec; 14(6):7391-7397. PubMed ID: 29344179
[TBL] [Abstract][Full Text] [Related]
13. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma.
Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J
Cells; 2019 May; 8(5):. PubMed ID: 31121964
[TBL] [Abstract][Full Text] [Related]
14. Efficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice.
Zhao J; Lu J; Zhou L; Zhao J; Dong Z
Hum Vaccin Immunother; 2018 May; 14(5):1294-1304. PubMed ID: 29360423
[TBL] [Abstract][Full Text] [Related]
15. The anticancer efficiency of the xenogeneic vaccine and the indication for its use.
Symchych TV; Fedosova NI; Karaman OM; Yevstratieva LM; Lisovenko HS; Voyejkova IM; Potebnia HP
Exp Oncol; 2014 Jun; 36(2):79-84. PubMed ID: 24980760
[TBL] [Abstract][Full Text] [Related]
16. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
Koliakos KK; Sapountzi Z; Papageorgiou A; Trachana V; Kotsinou S; Koliakos G
In Vivo; 2002; 16(6):511-8. PubMed ID: 12494895
[TBL] [Abstract][Full Text] [Related]
17. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
[TBL] [Abstract][Full Text] [Related]
18. Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity.
Li J; Chen J; Li X; Qian Y
Biochem Biophys Res Commun; 2017 Apr; 485(3):606-613. PubMed ID: 28238782
[TBL] [Abstract][Full Text] [Related]
19. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
20. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
